Scandinavian Medical Solutions A/S (SMSMED.CO)
DKK 4.29
(-5.36%)
DKK 4.29
(-5.36%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 34.72 Million DKK | 53.13% |
| 2022 | 22.67 Million DKK | 63.39% |
| 2021 | 13.88 Million DKK | 88.54% |
| 2020 | 7.36 Million DKK | 53.73% |
| 2019 | 4.78 Million DKK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 8.71 Million DKK | 0.0% |
| 2024 Q1 | 8.71 Million DKK | -31.19% |
| 2023 Q4 | 12.66 Million DKK | 84.61% |
| 2023 Q1 | 10.5 Million DKK | -19.26% |
| 2023 FY | 34.72 Million DKK | 53.13% |
| 2023 Q3 | 6.85 Million DKK | -63.18% |
| 2023 Q2 | 18.62 Million DKK | 77.26% |
| 2022 Q4 | 13.01 Million DKK | 93.22% |
| 2022 FY | 22.67 Million DKK | 63.39% |
| 2022 Q3 | 6.73 Million DKK | -26.74% |
| 2022 Q2 | 9.19 Million DKK | 99.67% |
| 2022 Q1 | 4.6 Million DKK | 68.48% |
| 2021 Q1 | 4.2 Million DKK | 0.0% |
| 2021 FY | 13.88 Million DKK | 88.54% |
| 2021 Q4 | 2.73 Million DKK | 0.0% |
| 2021 Q3 | 2.73 Million DKK | -35.04% |
| 2021 Q2 | 4.2 Million DKK | 0.0% |
| 2020 FY | 7.36 Million DKK | 53.73% |
| 2019 FY | 4.78 Million DKK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ambu A/S | 2.96 Billion DKK | 98.827% |
| ChemoMetec A/S | 367.59 Million DKK | 90.552% |
| Demant A/S | 16.54 Billion DKK | 99.79% |
| GN Store Nord A/S | 8.94 Billion DKK | 99.612% |
| ViroGates A/S | 5.8 Million DKK | -498.264% |